pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
REVUFORJ
REVUFORJ (REVUMENIB CITRATE)
1 INDICATIONS AND USAGE REVUFORJ is a menin inhibitor indicated for: the trea…
Menin
$SNDXSyndax Pharmaceuticals Inc
0 catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0 catalysts
REZDIFFRA
REZDIFFRA (RESMETIROM)
1 INDICATIONS AND USAGE REZDIFFRA is indicated in conjunction with diet and e…
Thyroid hormone receptor beta
$MDGLMADRIGAL PHARMACEUTICALS, INC.
catalysts
← prev
page 148 of 271
next →
131
Pain89
Neurology1
0
REZENOPY
REZENOPY (NALOXONE HYDROCHLORIDE)
1 INDICATIONS AND USAGE REZENOPY nasal spray is indicated for the emergency t…
Opioid receptors; mu/kappa/delta
$SCNXScienture Holdings, Inc.
0 catalysts
REZUROCK
REZUROCK (BELUMOSUDIL MESYLATE)
Kadmon Pharmaceuticals LLC
0 catalysts
REZZAYO
REZZAYO (REZAFUNGIN ACETATE)
Mundipharma EDO GmbH
0 catalysts
Preclinical
RFT-1041
Alzheimer's Disease
RAFT Pharmaceuticals LLC
0 catalysts
Preclinical
RFT-1124
Post-Operative Pain
RAFT Pharmaceuticals LLC
0 catalysts
Phase 2
RG-6351
Diabetic Macular Edema
Genentech Inc
0 catalysts
Phase 1
RG-6538
Refractory Multiple Myeloma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 1
RG-6540
Diffuse Large B-Cell Lymphoma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
RG-6596
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
RG-6794
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Genentech Inc
0 catalysts
Phase 1
RGDCRAdcox-2F
Pancreatic Cancer
University of Minnesota
0 catalysts
Phase 2
RGI-2001
Graft Versus Host Disease (GVHD)
REGiMMUNE Ltd
0 catalysts
Preclinical
RGN-6024
Glioblastoma Multiforme (GBM)
Reglagene Holding Inc
0 catalysts
Phase 1
RGT-61159
Adenoid Cystic Carcinoma (ACC)
Rgenta Therapeutics Inc
0 catalysts
Phase 1
RGVax
Human Papillomavirus (HPV) Associated Cancer
Pathovax LLC
0 catalysts
RHAPSIDO
RHAPSIDO (REMIBRUTINIB)
1 INDICATIONS AND USAGE RHAPSIDO ® is indicated for the treatment of chronic…
$NVSNOVARTIS AG
0 catalysts
Phase 1
RHB-204
(clarithromycin + clofazimine + rifabutin)
Crohn's Disease (Regional Enteritis)
$RDHLRedHill Biopharma Ltd.
0 catalysts
Preclinical
RHLAM-111
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Mu…
Sarcomatrix Therapeutics Corp
0 catalysts
pre_registration
RILPIVIRINE HYDROCHLORIDE
RILPIVIRINE HYDROCHLORIDE (RILPIVIRINE HYDROCHLORIDE)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Human immunodeficiency virus type 1 reverse transcriptase
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 1
RIM-730
Coronavirus Disease 2019 (COVID-19)
RNAimmune Inc
0 catalysts
RINGERS
RINGERS (SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE,)
BAXTER HLTHCARE
0 catalysts
RINVOQ
RINVOQ (UPADACITINIB)
1 INDICATIONS AND USAGE RINVOQ/RINVOQ LQ is a Janus kinase (JAK) inhibitor. R…
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
$ABBVAbbVie Inc.
0 catalysts
RINVOQ LQ
RINVOQ LQ (UPADACITINIB)
inflammatory bowel disease
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
$ABBVAbbVie Inc.
0 catalysts
Phase 2
RIV3 + rC19
Coronavirus Disease 2019 (COVID-19)
$SNYSanofi
0 catalysts
Phase 1
RIVASTIGMINE
RIVASTIGMINE (RIVASTIGMINE)
Dementia Associated With Alzheimer's Disease
Lachesis Biosciences Ltd
0 catalysts
RIVASTIGMINE TARTRATE
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
AUROBINDO PHARMA
0 catalysts
Preclinical
RK-33
Triple-Negative Breast Cancer (TNBC)
Natsar Pharmaceuticals Inc
0 catalysts